These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10604131)

  • 1. Systemic chemotherapy of advanced digestive neuroendocrine tumours.
    Rougier P; Ducreux M
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S202-6. PubMed ID: 10604131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment strategy of neuroendocrine tumors].
    Ducreux M; Baudin E; Schlumberger M
    Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of digestive neuroendocrine tumors].
    Rougier P; Toma C; Fabri MC; Ducreux M
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):117-20. PubMed ID: 7618833
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
    Dominguez S; Denys A; Menu Y; Ruszniewski P
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S213-5. PubMed ID: 10604133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
    Grozinsky-Glasberg S; Grossman AB; Korbonits M
    Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors.
    Vilar E; Salazar R; Pérez-García J; Cortes J; Oberg K; Tabernero J
    Endocr Relat Cancer; 2007 Jun; 14(2):221-32. PubMed ID: 17639039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic therapy for neuroendocrine tumours].
    Petrányi A; Bodoky G
    Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours.
    Oberg K
    Ann Oncol; 2001; 12 Suppl 2():S111-4. PubMed ID: 11762335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin analogs in oncology].
    Thomas F; Parmar H; Prevost G; Kuhn JM; Bejot JL; Moreau JP; Bogden A
    Bull Cancer; 1991; 78(8):693-707. PubMed ID: 1681967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for gastro-enteropancreatic endocrine tumours.
    O'Toole D; Hentic O; Corcos O; Ruszniewski P
    Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic therapy of gastroenteropancreatic (GEP) tumors.
    Syrigos KN; Sitara D; Georgiou E; Harrington KJ
    Anticancer Res; 2002; 22(2B):1311-4. PubMed ID: 12168943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Rougier P; Mitry E
    Digestion; 2000; 62 Suppl 1():73-8. PubMed ID: 10940691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of chemotherapy in the management of neuroendocrine tumors.
    Oberg K
    Endocrinol Metab Clin North Am; 1993 Dec; 22(4):941-52. PubMed ID: 8125079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant treatment of endocrine digestive tumors].
    Ruszniewski P
    Gastroenterol Clin Biol; 1994; 18(8-9):737-8. PubMed ID: 7875443
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
    Grozinsky-Glasberg S; Shimon I; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2008 Sep; 15(3):701-20. PubMed ID: 18524947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
    Faivre S; Sablin MP; Dreyer C; Raymond E
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine tumours of the gastrointestinal tract: Chemotherapy.
    Arnold R; Rinke A; Schmidt Ch; Hofbauer L
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):649-56. PubMed ID: 16183533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.